Дикий гормон. Удивительное медицинское открытие о том, как наш организм набирает лишний вес, почему мы в этом не виноваты и что поможет обуздать свой аппетит Фанг Джейсон

9. Simopoulos AP. Omega-3 fatty acids in health and disease and in growth and development. Am J Clin Nutr. 1991 Sep; 54(3):438–63.

10. Eades M. Framingham follies. The Blog of Michael R. Eades, M.D. [Internet]. 2006 Sep 28. Available from: http://www.proteinpower.com/drmike/cardiovascular-disease/framingham-follies/. Accessed 2015 Apr 12.

11. Nichols AB et al. Daily nutritional intake and serum lipid levels. The Tecumseh study. Am J Clin Nutr. 1976 Dec; 29(12):1384–92.

12. Garcia-Pamieri et al. Relationship of dietary intake to subsequent coronary heart disease incidence: The Puerto Rico Heart Health Program. Am J Clin Nutr. 1980 Aug; 33(8):1818–27.

13. Shekelle RB et al. Diet, serum cholesterol, and death from coronary disease: the Western Electric Study. N Engl J Med. 1981 Jan 8; 304(2):65–70.

14. Aro A et al. Transfatty acids in dairy and meat products from 14 European countries: the TRANS FAIR Study. Journal of Food Composition and Analysis. 1998 Jun; 11(2):150–160. doi: 10.1006/jfca.1998.0570. Accessed 2015 Apr 12.

15. Mensink RP, Katan MB. Effect of dietary trans fatty acids on high-density and low-density lipoprotein cholesterol levels in healthy subjects. N Engl J Med. 1990 Aug 16; 323(7):439–45.

16. Mozaffarian D et al. Trans fatty acids and cardiovascular disease. N Engl J Med. 2006 Apr 13; 354(15):1601–13.

17. Mente A et al. A systematic review of the evidence supporting a causal link between dietary factors and coronary heart disease. Arch Intern Med. 2009 Apr 13; 169(7):659–69.

18. Hu FB et al. Dietary fat intake and therisk of coronary heart disease in women. N Engl J Med. 1997 Nov 20; 337(21):1491–9.

19. Leosdottir M et al. Dietary fat intake and early mortality patterns: data from the Malmo Diet and Cancer Study. J Intern Med. 2005 Aug; 258(2):153–65.

20. Chowdhury R et al. Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis. Ann Intern Med. 2014 Mar 18; 160(6):398–406.

21. Siri-Tarino PW et al. Meta-analysis of prospective cohort studies evaluating the association of saturated fat with cardiovascular disease. Am J Clin Nutr. 2010 Mar; 91(3):535–46.

22. Yamagishi K et al. Dietary intake of saturated fatty acids and mortality from cardiovascular disease in Japanese. Am J Clin Nutr. First published 2010 August 4. doi: 10.3945/ ajcn.2009.29146. Accessed 2015 Apr 12.

23. Wakai K et al. Dietary intakes of fat and total mortality among Japanese populations with a low fat intake: the Japan Collaborative Cohort (JACC) Study. Nutr Metab (Lond). 2014 Mar 6; 11(1):12.

24. Ascherio A et al. Dietary fat and risk of coronary heart disease in men: cohort follow up study in the United States. BMJ. 1996 Jul 13; 313(7049):84–90.

25. Gillman MW et al. Margarine intake and subsequent heart disease in men. Epidemiology. 1997 Mar; 8(2):144–9.

26. Mozaffarian D et al. Dietary fats, carbohydrate, and progression of coronary atherosclerosis in postmenopausal women. Am J Clin Nutr. 2004 Nov; 80(5):1175–84.

27. Kagan A et al. Dietary and other risk factors for stroke in Hawaiian Japanese men. Stroke. 1985 May – Jun; 16(3):390–6.

28. Gillman MW et al. Inverse association of dietary fat with development of ischemic stroke in men. JAMA. 1997 Dec 24–31; 278(24):2145–50.

29. National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). National Institutes of Health; National Heart, Lung, and Blood Institute. 2002 Sep. Available from: http://www.nhlbi.nih.gov/files/docs/resources/heart/atp3full.pdf. Accessed 2015 Apr 12.

30. Kratz M et al. The relationship between high-fat dairy consumption and obesity, cardiovascular, and metabolic disease. Eur J Nutr. 2013 Feb; 52(1):1–24.

31. Rosell M et al. Association between dairy food consumption and weight change over 9 y in 19,352 perimenopausal women. Am J Clin Nutr. 2006 Dec; 84(6):1481–8.

32. Collier G, O’Dea K. The effect of co-ingestion of fat on the glucose, insulin and gastric inhibitory polypeptide responses to carbohydrate and protein. Am J Clin Nutr. 1983 Jun; 37(6):941–4.

33. Willett WC. Dietary fat plays a major role in obesity: no. Obes Rev. 2002 May; 3(2):59–68.

34. Howard BV et al. Low fat dietary pattern and risk of cardiovascular disease. JAMA. 2006 Feb 8; 295(6):655–66.

Глава 19: Что есть

1. Knowler WC et al. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet. 2009 Nov 14; 374(9702):1677–86.

2. Knowler WC et al. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet. 2009 Nov 14; 374(9702):1677–86.

3. Sacks FM et al. Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates. N Engl J Med. 2009 Feb 26; 360(9):859–73.

4. Johnston BC et al. Comparison of weight loss among named diet programs in overweight and obese adults: a meta-analysis. JAMA. 2014 Sep 3; 312(9):923–33.

5. Grassi D, Necozione S, Lippi C, Croce G, Valeri L, Pasqualetti P, Desideri G, Blumberg JB, Ferri C. Cocoa reduces blood pressure and insulin resistance and improves endothelium-dependent vasodilation in hypertensives. Hypertension. 2005 Aug; 46(2):398–405.

6. Grassi D et al. Blood pressure is reduced and insulin sensitivity increased in glucose-intolerant, hypertensive subjects after 15 days of consuming highpolyphenol dark chocolate. J. Nutr. 2008 Sep; 138(9):1671–6.

7. Djousse L et al. Chocolate consumption is inversely associated with prevalent coronary heart disease: the National Heart, Lung, and Blood Institute Family Heart Study. Clin Nutr. 2011 Apr; 30(2):182–7. doi: 10.1016/j.clnu.2010.08.005. Epub 2010 Sep 19. Accessed 2015 Apr 6.

8. Sabate J, Wien M. Nuts, blood lipids and cardiovascular disease. Asia Pac J Clin Nutr. 2010; 19(1):131–6.

9. Jenkins DJ et al. Possible benefit of nuts in type 2 diabetes. J. Nutr. 2008 Sep; 138(9):1752S–1756S.

10. Hernandez-Alonso P et al. Beneficial effect of pistachio consumption on glucose metabolism, insulin resistance, inflammation, and related metabolic risk markers: a randomized clinical trial. 2014 Aug 14. doi: 10.2337/dc14–1431. [Epub ahead of print] Accessed 2015 Apr 6.

11. Walton AG. All sugared up: the best and worst breakfast cereals for kids. Forbes [Internet]. 2014 May 15. Available at: http://www.forbes.com/sites/alicegwalton/2014/05/15/all-sugared-up-the-best-and-worst-breakfast-cereals-for-kids/. Accessed 2015 Apr 12.

12. Fernandez ML. Dietary cholesterol provided by eggs and plasma lipoproteins in healthy populations. Curr Opin Clin Nutr Metab Care. 2006 Jan; 9(1):8–12.

13. Mutungi G et al. Eggs distinctly modulate plasma carotenoid and lipoprotein subclasses in adult men following a carbohydrate-restricted diet. J Nutr Biochem. 2010 Apr; 21(4):261–7. doi: 10.1016/j.jnutbio.2008.12.011. Epub 2009 Apr 14.

14. Shin JY, Xun P, Nakamura Y, He K. Egg consumption in relation to risk of cardiovascular disease and diabetes: a systematic review and meta-analysis. Am J Clin Nutr. 2013 Jul; 98(1):146–59.

15. Rong Y et al. Egg consumption and risk of coronary heart disease and stroke: dose-response meta-analysis of prospective cohort studies. BMJ. 2013; 346:e8539. doi: 10.1136/bmj.e8539. Accessed 2015 Apr 6.

16. Cordain L et al. Influence of moderate chronic wine consumption on insulin sensitivity and other correlates of syndrome X in moderately obese women. Metabolism. 2000 Nov; 49(11):1473–8.

17. Cordain L et al. Influence of moderate chronic wine consumption on insulin sensitivity and other correlates of syndrome X in moderately obese women. Metabolism. 2000 Nov; 49(11):1473–8.

18. Napoli R et al. Red wine consumption improves insulin resistance but not endothelial function in type 2 diabetic patients. Metabolism. 2005 Mar; 54(3):306–13.

19. Huxley R et al. Coffee, decaffeinated coffee, and tea consumption in relation to incident type 2 diabetes mellitus: a systematic review with meta-analysis. Arch Intern Med. 2009 Dec 14; 169(22):2053–63.

20. Gmez-Ruiz JA, Leake DS, Ames JM. In vitro antioxidant activity of coffee compounds and their metabolites. J Agric Food Chem. 2007 Aug 22; 55(17):6962–9.

21. Milder IE, Arts I, Cvan de Putte B, Venema DP, Hollman PC. Lignan contents of Dutch plant foods: a database including lariciresinol, pinoresinol, secoisolariciresinol and metairesinol. Br J Nutr. 2005 Mar; 93(3):393–402.

22. Clifford MN. Chlorogenic acids and other cinnamates: nature, occurrence and dietary burden. J Sci Food Agric. 1999; 79(5):362–72.

23. Huxley R et al. Coffee, decaffeinated coffee, and tea consumption in relation to incident type 2 diabetes mellitus: a systematic review with meta-analysis. Arch Intern Med. 2009 Dec 14; 169(22):2053–63.

24. Van Dieren S et al. Coffee and tea consumption and risk of type 2 diabetes. Diabetologia. 2009 Dec; 52(12):2561–9.

25. Odegaard AO et al. Coffee, tea, and incident type 2 diabetes: the Singapore Chinese Health Study. Am J Clin Nutr. 2008 Oct; 88(4):979–85.

26. Freedman ND, Park Y, Abnet CC, Hollenbeck AR, Sinha R. Association of coffee drinking with total and cause-specific mortality. N Engl J Med. 2012 May 17; 366(20):1891–904.

27. Lopez-Garcia E, van Dam RM, Li TY, Rodriguez-Artalejo F, Hu FB. The relationship of coffee consumption with mortality. Ann Intern Med. 2008 Jun 17; 148(2):904–14.

28.Eskelinen MH, Kivipelto M. Caffeine as a protective factor in dementia and Alzheimer’s disease. J Alzheimers Dis. 2010; 20 Suppl 1:167–74.

29. Santos C et al. Caffeine intake and dementia: systematic review and meta-analysis. J Alzheimers Dis. 2010; 20 Suppl 1:S187–204. doi: 10.3233/JAD-2010–091387. Accessed 2015 Apr 6.

30. Hernan MA et al. A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson’s disease. Ann Neurol. 2002 Sep; 52(3):276–84.

31. Ross GW et al. Association of coffee and caffeine intake with the risk of Parkinson disease. JAMA. 2000 May; 283(20):2674–9.

32. Klatsky AL et al. Coffee, cirrhosis, and transaminase enzymes. Arch Intern Med. 2006 Jun 12; 166(11):1190–5.

33. Klatsky AL et al. Coffee, cirrhosis, and transaminase enzymes. Arch Intern Med. 2006 Jun 12; 166(11):1190–5.

34. Kobayashi Y, Suzuki M, Satsu H et al. Green tea polyphenols inhibit the sodiumdependent glucose transporter of intestinal epithelial cells by a competitive mechanism. J Agric Food Chem. 2000 Nov; 48(11):5618–23.

35. Crespy V, Williamson GA. A review of the health effects of green tea catechins in in vivo animal models. J Nutr. 2004 Dec; 134(12 suppl):3431S–3440S.

36. Cabrera C et al. Beneficial effects of green tea: a review. J Am Coll Nutr. 2006 Apr; 25(2):79–99.

37. Hursel, R, Westerterp-Plantenga MS. Catechin- and caffeine-rich teas for control of body weight in humans. Am J Clin Nutr. 2013 Dec; 98(6):1682S–93S.

38. Dulloo AG et al. Green tea and thermogenesis: interactions between catechinpolyphenols, caffeine and sympathetic activity. Inter J Obesity. 2000 Feb; 24(2):252–8.

39. Venables MC et al. Green tea extract ingestion, fat oxidation, and glucose tolerance in healthy humans. Am J Clin Nutr. 2008 Mar; 87(3):778–84.

40. Dulloo AG et al. Efficacy of a green tea extract rich in catechin polyphenols and caffeine in increasing 24-h energy expenditure and fat oxidation in humans. Am J Clin Nutr. 1999 Dec; 70(6):1040–5.

41. Koo MWL, Cho CH. Pharmacological effects of green tea on the gastrointestinal system. Eur J Pharmacol. 2004 Oct 1; 500(1–3):177–85.

42. Hursel R Viechtbauer W, Westerterp-Plantenga, MS. The effects of green tea on weight loss and weight maintenance: a meta-analysis. Int J Obes (Lond). 2009 Sep; 33(9):956–61. doi: 10.1038/ijo.2009.135. Epub 2009 Jul 14. Accessed 6 Apr 2015.

43. Van Dieren S et al. Coffee and tea consumption and risk of type 2 diabetes. Diabetologia. 2009 Dec; 52(12):2561–9.

44. Odegaard, AO et al. Coffee, tea, and incident type 2 diabetes: the Singapore Chinese Health Study. Am J Clin Nutr. 2008 Oct; 88(4):979–85.

45. Patrick L, Uzick M. Cardiovascular disease: C-reactive protein and the inflammatory disease paradigm: HMG-CoA reductase inhibitors, alpha-tocopherol, red yeast rice, and olive oil polyphenols. A review of the literature. Alternative Medicine Review. 2001 Jun; 6(3):248–71.

46. Aviram M, Eias K. Dietary olive oil reduces low-density lipoprotein uptake by macrophages and decreases the susceptibility of the lipoprotein to undergo lipid peroxidation. Ann Nutr Metab. 1993; 37(2):75–84.

47. Smith RD et al. Long-term monounsaturated fatty acid diets reduce platelet aggregation in healthy young subjects. Br J Nutr. 2003 Sep; 90(3):597–606.

48. Ferrara LA et al. Olive oil and reduced need for antihypertensive medications. Arch Intern Med. 2000 Mar 27; 160(6):837–42.

49. Martnez-Gonzlez MA et al. Olive oil consumption and risk of CHD and/or stroke: a meta-analysis of case-control, cohort and intervention studies. Br J Ntru. 2014 Jul; 112(2):248–59.

50. Chen M, Pan A, Malik VS, Hu FB. Effects of dairy intake on body weight and fat: a meta-analysis of randomized controlled trials. Am J Clin Nutr. 2012 Oct; 96(4):735–47.

51. Mozaffarian, D et al. Trans-palmitoleic acid, metabolic risk factors, and new-onset diabetes in U.S. adults: a cohort study. Ann Intern Med. 2010 Dec 21; 153(12):790–9.

52. Hyman M. The super fiber that controls your appetite and blood sugar. Huffington Post [Internet]. 2010 May 29 (updated 2013 Nov 11). Available from: http://www.huffingtonpost.com/dr-mark-hyman/fiber-health-the-super-fi_b_594153.html. Accessed 2015 Apr 6.

53. Sugiyama M et al. Glycemic index of single and mixed meal foods among common Japanese foods with white rice as a reference food. Euro J Clin Nutr. 2003 Jun; 57(6):743–52. doi:10.1038/sj.ejcn.1601606. Accessed 2015 Apr 6.

Глава 20: Когда есть

1. Arbesmann R. Fasting and prophecy in pagan and Christian antiquity. Traditio. 1951; 7:1–71.

2. Lamine F et al. Food intake and high density lipoprotein cholesterol levels changes during Ramadan fasting in healthy young subjects. Tunis Med. 2006 Oct; 84(10):647–650.

3. Felig P. Starvation. In: DeGroot LJ, Cahill GF Jr et al., editors. Endocrinology: Vol 3. New York: Grune & Stratton; 1979. pp. 1927–40.

4. Coffee CJ, Quick look: metabolism. Hayes Barton Press; 2004. p. 169.

5. Owen OE, Felig P. Liver and kidney metabolism during prolonged starvation. J Clin Invest. 1969 Mar; 48:574–83.

6. Merrimee TJ, Tyson JE. Stabilization of plasma glucose during fasting: normal variation in two separate studies. N Engl J Med. 1974 Dec 12; 291(24):1275–8.

7. Heilbronn LK. Alternate-day fasting in nonobese subjects: effects on body weight, body composition, and energy metabolism. Am J Clin Nutr. 2005; 81:69–73.

8. Halberg N. Effect of intermittent fasting and refeeding on insulin action in healthy men. J Appl Physiol. 1985 Dec; 99(6):2128–36.

9. Rudman D et al. Effects of human growth hormone in men over 60 years old. N Engl J Med. 1990 Jul 5; 323(1):1–6.

10. Ho KY et al. Fasting enhances growth hormone secretion and amplifies the complex rhythms of growth hormone secretion in man. J Clin Invest. 1988 Apr; 81(4):968–75.

11. Drenick EJ. The effects of acute and prolonged fasting and refeeding on water, electrolyte, and acid-base metabolism. In: Maxwell MH, Kleeman CR, editors. Clinical disorders of fluid and electrolyte metabolism. 3rd ed. New York: McGraw-Hill; 1979.

12. Kerndt PR et al. Fasting: the history, pathophysiology and complications. West J Med. 1982 Nov; 137(5):379–99.

13. Stewart WK, Fleming LW. Features of a successful therapeutic fast of 382 days’ duration. Postgrad Med J. 1973 Mar; 49(569):203–9.

14. Lennox WG. Increase of uric acid in the blood during prolonged starvation. JAMA. 1924 Feb 23; 82(8):602–4.

15. Drenick EJ et al. Prolonged starvation as treatment for severe obesity. JAMA. 1964 Jan 11; 187:100–5.

16. Felig P. Starvation. In: DeGroot LJ, Cahill GF Jr et al., editors. Endocrinology: Vol 3. New York: Grune & Stratton; 1979. pp. 1927–40.

17. Bhutani S et al. Improvements in coronary heart disease risk indicators by alternate-day fasting involve adipose tissue modulations. Obesity. 2010 Nov; 18(11):2152–9.

18. Stote KS et al. A controlled trial of reduced meal frequency without caloric restriction in healthy, normal-weight, middle-aged adults. Am J Clin Nutr. 2007 Apr; 85(4):981–8.

19. Heilbronn LK. Alternate-day fasting in nonobese subjects: effects on body weight, body composition, and energy metabolism. Am J Clin Nutr. 2005; 81:69–73.

20. Zauner C. Resting energy expenditure in short-term starvation is increased as a result of an increase in serum norepinephrine. Am J Clin Nutr. 2000 Jun; 71(6):1511–5.

21. Stubbs RJ et al. Effect of an acute fast on energy compensation and feeding behaviour in lean men and women. Int J Obesity. 2002 Dec; 26(12):1623–8.

22. Duncan GG. Intermittent fasts in the correction and control of intractable obesity. Trans Am Clin Climatol Assoc 1963; 74:121–9.

23. Duncan DG et al. Correction and control of intractable obesity. Practical application of Intermittent Periods of Total Fasting. JAMA. 1962; 181(4):309–12.

24. Drenick E. Prolonged starvation as treatment for severe obesity. AMA. 1964 Jan 11; 187:100–5.

25. Thomson TJ et al. Treatment of obesity by total fasting for up to 249 days. Lancet. 1966 Nov 5; 2(7471):992–6.

26. Kerndt PR et al. Fasting: the history, pathophysiology and complications. West J Med. 1982 Nov; 137(5):379–99.

27. Folin O, Denis W. On starvation and obesity, with special reference to acidosis. Greystone J Biol Chem. 1915; 21:183–92.

28. Bloom WL. Fasting as an introduction to the treatment of obesity. Metabolism. 1959 May; 8(3):214–20.

29. Stewart WK, Fleming LW. Features of a successful therapeutic fast of 382 days’ duration. Postgrad Med J. 1973 Mar; 49(569):203–9.

30. Merimee TJ, Tyson JE. Stabilization of plasma glucose during fasting: Normal variation in two separate studies. N Engl J Med. 1974 Dec 12; 291(24):1275–8.

31. Bloom WL. Fasting ketosis in obese men and women. J Lab Clin Med. 1962 Apr; 59:605–12.

32. Forbes GB. Weight loss during fasting: implications for the obese. Am J Clin Nutr. 1970 Sep; 23:1212–19.

33. Harvie MN et al. The effects of intermittent or continuous energy restriction on weight loss and metabolic disease risk markers. Int J Obes (Lond). 2011 May; 35(5):714–27.

34. Klempel MC et al. Intermittent fasting combined with calorie restriction is effective for weight loss and cardio-protection in obese women. Nutr J. 2012; 11:98. doi: 10.1186/1475–2891-11–98. Accessed 2015 Apr 8.

35. Williams KV et al. The effect of short periods of caloric restriction on weight loss and glycemic control in type 2 diabetes. Diabetes Care. 1998 Jan; 21(1):2–8.

36. Koopman KE et al. Hypercaloric diets with increased meal frequency, but not meal size, increase intrahepatic triglycerides: A randomized controlled trial. Hepatology. 2014 Aug; 60(2); 545–55.

37. Yanovski JA, Yanovski SZ, Sovik KN, Nguyen TT, O’Neil PM, Sebring NG. A prospective study of holiday weight gain. N Engl J Med. 2000 Mar 23; 342(12):861–7.

Приложение B

1. Hiebowicz J et al. Effect of cinnamon on post prandial blood glucose, gastric emptying and satiety in healthy subjects. Am J Clin Nutr. 2007 Jun; 85(6):1552–6.

2. Greenberg JA, Geliebter A. Coffee, hunger, and peptide YY. J Am Coll Nutr. 2012 Jun; 31(3):160–6.